immunotherapy, adoptive

Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sources
Andrea Schmidts, Leah C Marsh, Ambike A Srivastava, Amanda A Bouffard, Angela C Boroughs, Irene Scarfò, Rebecca C Larson, Felipe Bedoya, Bryan D Choi, Matthew J Frigault, Stefanie R Bailey, Mark B Leick, Sonika Vatsa, Michael C Kann, Michelle S Prew, Benjamin P Kleinstiver, J Keith Joung, Marcela V Maus

Journal for ImmunoTherapy of Cancer Sep 2020, 8 (2) e000990; DOI: 10.1136/jitc-2020-000990
Safety and efficacy of CAR-T cell targeting BCMA in patients with multiple myeloma coinfected with chronic hepatitis B virus
Lu Han, Jian Zhou, Keshu Zhou, Xinghu Zhu, Lingdi Zhao, Baijun Fang, Qingsong Yin, Xudong Wei, Hu Zhou, Linlin Li, Bengling Xu, Jishuai Zhang, Yongping Song, Quanli Gao

Journal for ImmunoTherapy of Cancer Aug 2020, 8 (2) e000927; DOI: 10.1136/jitc-2020-000927
Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up
Joost H van den Berg, Bianca Heemskerk, Nienke van Rooij, Raquel Gomez-Eerland, Samira Michels, Maaike van Zon, Renate de Boer, Noor A M Bakker, Annelies Jorritsma-Smit, Marit M van Buuren, Pia Kvistborg, Hergen Spits, Remko Schotte, Henk Mallo, Matthias Karger, Joris A van der Hage, Michel W J M Wouters, Loes M Pronk, Marnix H Geukes Foppen, Christian U Blank, Jos H Beijnen, Bastiaan Nuijen, Ton N Schumacher, John B A G Haanen

Journal for ImmunoTherapy of Cancer Aug 2020, 8 (2) e000848; DOI: 10.1136/jitc-2020-000848
Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
Troels Holz Borch, Rikke Andersen, Eva Ellebaek, Özcan Met, Marco Donia, Inge Marie Svane

Journal for ImmunoTherapy of Cancer Jul 2020, 8 (2) e000668; DOI: 10.1136/jitc-2020-000668
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity
Jia Wei, Jianping Zhao, Meifang Han, Fankai Meng, Jianfeng Zhou

Journal for ImmunoTherapy of Cancer Jul 2020, 8 (2) e000862; DOI: 10.1136/jitc-2020-000862
41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo
Matteo Libero Baroni, Diego Sanchez Martinez, Francisco Gutierrez Aguera, Heleia Roca Ho, Maria Castella, Samanta Romina Zanetti, Talia Velasco Hernandez, Rafael Diaz de la Guardia, Julio Castaño, Eduardo Anguita, Susana Vives, Josep Nomdedeu, Helene Lapillone, Anne E Bras, Vincent H J van der Velden, Jordi Junca, Pedro Marin, Alex Bataller, Jordi Esteve, Binje Vick, Irmela Jeremias, Angel Lopez, Marc Sorigue, Clara Bueno, Pablo Menendez

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000845; DOI: 10.1136/jitc-2020-000845
Nanopore sequencing as a scalable, cost-effective platform for analyzing polyclonal vector integration sites following clinical T cell therapy
Ping Zhang, Devika Ganesamoorthy, Son Hoang Nguyen, Raymond Au, Lachlan J Coin, Siok-Keen Tey

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000299; DOI: 10.1136/jitc-2019-000299
Histiocyte predominant myocarditis resulting from the addition of interferon gamma to cyclophosphamide-based lymphodepletion for adoptive cellular therapy
Brett A Schroeder, Ralph Graeme Black, Sydney Spadinger, Shihong Zhang, Karan Kohli, Jianhong Cao, Jose G Mantilla, Ernest U Conrad, Stanley R Riddell, Robin L Jones, Cassian Yee, Seth M Pollack

Journal for ImmunoTherapy of Cancer Apr 2020, 8 (1) e000247; DOI: 10.1136/jitc-2019-000247
Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes
Lucine Marotte, Sylvain Simon, Virginie Vignard, Emilie Dupre, Malika Gantier, Jonathan Cruard, Jean-Baptiste Alberge, Melanie Hussong, Cecile Deleine, Jean-Marie Heslan, Jonathan Shaffer, Tiffany Beauvais, Joelle Gaschet, Emmanuel Scotet, Delphine Fradin, Anne Jarry, Tuan Nguyen, Nathalie Labarriere

Journal for ImmunoTherapy of Cancer Jan 2020, 8 (1) e000311; DOI: 10.1136/jitc-2019-000311

Log in using your username and password

Main menu

Log in using your username and password

You are here

immunotherapy, adoptive